Heidi Schueller

Heidi Schueller has a diverse work experience in the pharmaceutical industry. Heidi started their career as a Drug Safety Associate I at the Strategic Solutions Division of PRA Health Sciences in 2011. Heidi progressed to the role of Drug Safety Associate II in 2015 and then became a DSA III in April 2020. Heidi joined IQVIA in December 2020 as an Associate Manager in Safety Operations. In December 2021, they transitioned to Elevar Therapeutics as a DSPV Senior Operations Manager. Currently, they hold the position of Director of Pharmacovigilance Operations at Elevar Therapeutics starting from July 2022.

Heidi Schueller obtained their Bachelor of Science (BS) degree in Public Health Education and Promotion from Temple University, where they studied from 1985 to 1989. In addition, they recently obtained a certification in GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus) from the CITI Program in December 2021.